“…As she detailed, in Sweden, key stakeholders within addiction treatment have resisted a wholly biomedical understanding of alcohol and other drug problems, with social models of addiction historically engrained within treatment settings. Taking a US perspective, Schmidt (2018) argued that moralized formulations of the disease concept were present in Benjamin Rush's original formulation of alcoholism as a 'disease of the will' (Levine, 1985;Schmidt, 1995), and continue to pose problems for clients because they have never fully dropped away (e.g., leading to stigma which deters people from accessing treatment). Schmidt argued this was problematic because addiction treatment stakes its legitimacy on evidence-based medical science rather than ideological systems of belief which remain pervasive within treatment.…”